why cbdMD Inc. [YCBD] is a Good Choice for Investors After New Price Target of $4.27

cbdMD Inc. [AMEX: YCBD] jumped around 0.08 points on Tuesday, while shares priced at $3.06 at the close of the session, up 2.68%. The company report on July 27, 2020 that cbdMD, Inc. To Host Conference Call To Discuss Third Quarter 2020 Results.

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A ), one of the leading, and most highly trusted and recognized, cannabidiol (CBD) brands, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Wednesday, August 12, 2020, to discuss the company’s third quarter of fiscal 2020 financial results and business progress.


cbdMD Inc. stock is now 35.40% up from its year-to-date (YTD) trading value. YCBD Stock saw the intraday high of $3.18 and lowest of $3.00 per share. The company’s 52-week high price is 5.35, which means current price is +509.56% above from all time high which was touched on 07/28/20.

Compared to the average trading volume of 2.05M shares, YCBD reached a trading volume of 1069235 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about cbdMD Inc. [YCBD]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for YCBD shares is $4.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on YCBD stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for cbdMD Inc. is set at 0.23, with the Price to Sales ratio for YCBD stock in the period of the last 12 months amounting to 4.25. The Price to Book ratio for the last quarter was 1.21, with the Price to Cash per share for the same quarter was set at 0.30.

How has YCBD stock performed recently?

cbdMD Inc. [YCBD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.91. With this latest performance, YCBD shares gained by 74.86% in over the last four-week period, additionally plugging by 178.18% over the last 6 months – not to mention a drop of -24.26% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for YCBD stock in for the last two-week period is set at 81.87, with the RSI for the last a single of trading hit 86.27, and the three-weeks RSI is set at 77.95 for cbdMD Inc. [YCBD]. The present Moving Average for the last 50 days of trading for this stock 1.98, while it was recorded at 2.83 for the last single week of trading, and 1.90 for the last 200 days.

cbdMD Inc. [YCBD]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and cbdMD Inc. [YCBD] shares currently have an operating margin of -60.72 and a Gross Margin at +61.37. cbdMD Inc.’s Net Margin is presently recorded at -192.08.

Return on Total Capital for YCBD is now -55.64, given the latest momentum, and Return on Invested Capital for the company is -180.95. Return on Equity for this stock declined to -180.95, with Return on Assets sitting at -82.95.

Reflecting on the efficiency of the workforce at the company, cbdMD Inc. [YCBD] managed to generate an average of -$249,614 per employee. Receivables Turnover for the company is 6.88 with a Total Asset Turnover recorded at a value of 0.43.cbdMD Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.20 and a Current Ratio set at 4.30.

Earnings analysis for cbdMD Inc. [YCBD]

With the latest financial reports released by the company, cbdMD Inc. posted -1.19/share EPS, while the average EPS was predicted by analysts to be reported at -0.1/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -1,090.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for YCBD.

Insider trade positions for cbdMD Inc. [YCBD]

There are presently around $20 million, or 13.90% of YCBD stock, in the hands of institutional investors. The top three institutional holders of YCBD stocks are: BLACKROCK INC. with ownership of 1,460,863, which is approximately 57.064% of the company’s market cap and around 0.80% of the total institutional ownership; VANGUARD GROUP INC, holding 1,303,334 shares of the stock with an approximate value of $3.99 million in YCBD stocks shares; and ADVISORSHARES INVESTMENTS LLC, currently with $1.34 million in YCBD stock with ownership of nearly 7.855% of the company’s market capitalization.

Positions in cbdMD Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 33 institutional holders increased their position in cbdMD Inc. [AMEX:YCBD] by around 3,194,574 shares. Additionally, 13 investors decreased positions by around 749,503 shares, while 11 investors held positions by with 2,542,048 shares. The mentioned changes placed institutional holdings at 6,486,125 shares, according to the latest SEC report filing. YCBD stock had 10 new institutional investments in for a total of 686,158 shares, while 4 institutional investors sold positions of 54,891 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam